Salta alla navigazione principale Salta alla ricerca Salta al contenuto principale

Practical recommendations for the management of diabetes in patients with COVID-19

  • S. R. Bornstein*
  • , F. Rubino
  • , K. Khunti
  • , Geltrude Mingrone
  • , D. Hopkins
  • , A. L. Birkenfeld
  • , B. Boehm
  • , S. Amiel
  • , R. I. Holt
  • , J. S. Skyler
  • , J. H. DeVries
  • , E. Renard
  • , R. H. Eckel
  • , P. Zimmet
  • , K. G. Alberti
  • , J. Vidal
  • , B. Geloneze
  • , J. C. Chan
  • , L. Ji
  • , B. Ludwig
  • *Autore corrispondente per questo lavoro
  • Faculty of Life Sciences & Medicine
  • King's College Hospital
  • University of Leicester
  • Kings Health Partners
  • Nanyang Technological University
  • Tan Tock Seng Hospital
  • Institut national de la santé et de la recherche médicale
  • Monash University
  • CIBER - Center for Biomedical Research Network
  • Universidade Estadual de Campinas
  • Peking University
  • Technische Universität Dresden
  • University of Zurich
  • Technische Universität Dresden (TU Dresden)
  • Deutsches Zentrum für Diabetesforschung

Risultato della ricerca: Contributo in rivista › Articolo

294   !!Link opens in a new tab Citazioni (SciVal)

Abstract

Diabetes is one of the most important comorbidities linked to the severity of all three known human pathogenic coronavirus infections, including severe acute respiratory syndrome coronavirus 2. Patients with diabetes have an increased risk of severe complications including Adult Respiratory Distress Syndrome and multi-organ failure. Depending on the global region, 20–50% of patients in the coronavirus disease 2019 (COVID-19) pandemic had diabetes. Given the importance of the link between COVID-19 and diabetes, we have formed an international panel of experts in the field of diabetes and endocrinology to provide some guidance and practical recommendations for the management of diabetes during the pandemic. We aim to briefly provide insight into potential mechanistic links between the novel coronavirus infection and diabetes, present practical management recommendations, and elaborate on the differential needs of several patient groups.
Lingua originaleInglese
pagine (da-a)546-550
Numero di pagine5
RivistaThe Lancet Diabetes and Endocrinology
Volume8
Numero di pubblicazione6
DOI
Stato di pubblicazionePubblicato - 2020

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

  1. SDG 3 - Salute e benessere
    SDG 3 Salute e benessere

All Science Journal Classification (ASJC) codes

  • Medicina Interna
  • Endocrinologia, Diabete e Metabolismo
  • Endocrinologia

Keywords

  • Betacoronavirus
  • COVID-19
  • Comorbidity
  • Contraindications
  • Coronavirus Infections
  • Diabetes Mellitus
  • Drug
  • Humans
  • Hypoglycemic Agents
  • Multiple Organ Failure
  • Pandemics
  • Pneumonia
  • Practice Guidelines as Topic
  • Respiratory Distress Syndrome
  • SARS-CoV-2
  • Type 1
  • Type 2
  • Viral

Fingerprint

Entra nei temi di ricerca di 'Practical recommendations for the management of diabetes in patients with COVID-19'. Insieme formano una fingerprint unica.

Cita questo